ESR1 and cancer: The underestimation of breast cancer mortality we observed for both second estrogen receptor–positive and estrogen receptor–negative cancers is consistent with our prior observation that women with a second breast cancer have a higher risk of death than women with a first breast cancer, even after considering tumor characteristics of the initial and the second cancer and the time interval between 2 cancer (3,22-25).